2-Oxoglutarate-dependent dioxygenases in cancer

JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …

[HTML][HTML] Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

C Wigerup, S Påhlman, D Bexell - Pharmacology & therapeutics, 2016 - Elsevier
Insufficient tissue oxygenation, or hypoxia, contributes to tumor aggressiveness and has a
profound impact on clinical outcomes in cancer patients. At decreased oxygen tensions …

Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

X Yuan, W Ruan, B Bobrow, P Carmeliet… - Nature Reviews Drug …, 2024 - nature.com
Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for
adaptation of metazoans to limited oxygen availability. Recently, HIF activation and …

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas

R García-Carbonero, F Matute Teresa… - Clinical and …, 2021 - Springer
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …

The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma …

L Fishbein, J Del Rivero, T Else, JR Howe, SL Asa… - Pancreas, 2021 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the medical management and surveillance of metastatic and …

[HTML][HTML] Belzutifan, a potent HIF2α inhibitor, in the Pacak–Zhuang syndrome

J Kamihara, KV Hamilton, JA Pollard… - … England Journal of …, 2021 - Mass Medical Soc
The integration of genomic testing into clinical care enables the use of individualized
approaches to the management of rare diseases. We describe the use of belzutifan, a potent …

JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views

N Gangat, N Szuber, A Pardanani, A Tefferi - Leukemia, 2021 - nature.com
JAK2 unmutated or non-polycythemia vera (PV) erythrocytosis encompasses both hereditary
and acquired conditions. A systematic diagnostic approach begins with documentation of …

Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment

VL Martucci, K Pacak - Current problems in cancer, 2014 - Elsevier
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors that arise from the
chromaffin cells of the adrenal glands. Paragangliomas (PGLs), the extra-adrenal …

Neoplasms of the neuroendocrine pancreas: an update in the classification, definition, and molecular genetic advances

JM Guilmette, V Nosé - Advances in anatomic pathology, 2019 - journals.lww.com
This review focuses on discussing the main modifications of the recently published 2017
WHO Classification of Neoplasms of the Neuroendocrine Pancreas (panNEN). Recent …

Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma/paraganglioma: an National Institutes of Health study

H Turkova, T Prodanov, M Maly, V Martucci, K Adams… - Endocrine practice, 2016 - Elsevier
ABSTRACT Objective: Overall about 10 to 20% of pheochromocytomas/paragangliomas
(PHEOs/PGLs) are metastatic, with higher metastatic potential observed in succinate …